Lung Tumor Protein Synthesis Rates in Lung Cancer Patients
NCT05794529
Summary
The current study will recruit lung cancer patients to measure tissue protein synthesis rates of non-small cell lung carcinomas and healthy lung tissue. The protein synthesis rates of healthy lung tissue will be compared to lung tumor tissue to establish the remodeling characteristics of healthy versus cancerous lung tissues. We will also examine whether tissue protein synthesis rates of non-small cell lung carcinomas are associated with various tumor- (i.e., size, subclassification) and patient-derived (i.e., inflammation, lung function, smoking status, and smoking history) parameters.
Eligibility
Inclusion Criteria: 1. Aged 18-65 years 2. Compos mentis 3. Diagnosed with lung cancer, with treatment requiring a thoracotomy or VATS lobectomy Exclusion Criteria: 1. Neoadjuvant chemo- or radiotherapy in the past four weeks 2. Use of systemic steroids in the past four week 3. Insulin-dependent diabetes mellitus 4. Pregnancy
Conditions2
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
NCT05794529